elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47558373-1612D7D6-C584-4450-8008-2EAF689FCEE2
Q47558373-1612D7D6-C584-4450-8008-2EAF689FCEE2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47558373-1612D7D6-C584-4450-8008-2EAF689FCEE2
Small Molecules and Antibodies for Zika Therapy.
P2860
Q47558373-1612D7D6-C584-4450-8008-2EAF689FCEE2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47558373-1612D7D6-C584-4450-8008-2EAF689FCEE2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d037f616a67f96ce18221c08def97c4b68173b86
P2860
Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial.